Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin β chain

Blood

Volumn 88, Issue 6, 1996, Pages 2050-2061

  Odrljin, Tatjana M ^b   Shainoff, John R ^b   Lawrence, Sarah O ^b   Simpson Haidaris, Patricia J ^a  

^a Thrombosis and Hemostasis Program   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; HEPARAN SULFATE; HEPARIN; IODINE 125; MONOCLONAL ANTIBODY;

AFFINITY CHROMATOGRAPHY; ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; CROSSED IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; THROMBOSIS;

EID: 0029847785     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2050.bloodjournal8862050     Document Type: Article

References (47)

1. Drake SL, Klein DJ, Mickelson DJ, Oegema TR, Furcht LT, McCarthy JB: Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide. J Cell Biol 117:1331, 1992
2. Woods A, Couchman JR: Syndecan 4 heparan sulfate proteoglycan is a selectively enriched and widespread focal adhesion component. Mol Biol Cell 5:185, 1994
3. Woods A, McCarthey JB, Furcht LT, Couchman JR: A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion. Mol Biol Cell 4:605, 1993
4. Charonis AS, Skubitz AP, Koliakos GG, Reger LA, Dege J, Vogel AM, Furcht LT: A novel synthetic peptide from the B1 chain of laminin with heparin-binding and cell adhesion-promoting activities. J Cell Biol 107:1253, 1988
5. Asch AS, Tepler J, Silbiger S, Nachman RL: Cellular attachment to thrombospondin. Cooperative interactions between receptor systems. J Biol Chem 266:1740, 1991
6. Sipes JM, Guo N, Negre E, Vogel T, Krutzsch HC, Roberts DD: Inhibition of fibronectin binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type I repeat of thrombospondin. J Cell Biol 121:469, 1993
7. Fujimura Y, Titani K, Holland LZ, Roberts JR, Kostel P, Ruggeri ZM: A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 262:1734, 1987
8. Mohri H, Iwamatsu A, Ohkubo T: Heparin binding sites are located in a 40-kD γ-chain and a 36-kD β-chain fragment isolated from human fibrinogen. Thromb Thrombolysis 1:49, 1994
9. Cardin AD, Weintraub HJ: Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21, 1989
10. Bunce LA, Sporn LA, Francis CW: Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the β chain. J Clin Invest 89:842, 1992
11. Sporn LA, Bunce LA, Francis CW: Cell proliferation on fibrin: Modulation by fibrinopeptide cleavage. Blood 86:1082, 1995
12. Ribes JA, Ni F, Wagner DD, Francis CW: Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin β chain. J Clin Invest 84:435, 1989
13. Courtney MA, Bunce LA, Neroni LA, Simpson-Haidaris PJ: Cloning of the complete coding sequence of rat fibrinogen Bβ chain cDNA: Interspecies conservation of fibrin β15-42 primary structure. Blood Coagul Fibrinolysis 5:487, 1994
14. 2 terminus. J Biol Chem 260:2994, 1985
15. Erban JK, Wagner DD: A 130-kDa protein on endothelial cells binds to amino acids 15-42 of the Bβ chain of fibrinogen. J Biol Chem 267:2451, 1992
16. Panetti TS, McKeown-Longo PJ: The αvβ5 integrin receptor regulates receptor-mediated endocytosis of vitronectin. J Biol Chem 268:11492, 1993
17. Panetti TS, McKeown-Longo PJ: Receptor-mediated endocytosis of vitronectin is regulated by its conformational state. J Biol Chem 268:11988, 1993
18. Hotchkiss KA, Chesterman CN, Hogg PJ: Inhibition of heparin activity in plasma by soluble fibrin: Evidence for ternary thrombin-fibrin-heparin complex formation. Blood 84:498, 1994
19. Hogg PJ, Jackson CM: Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: Implications for heparin efficacy. Proc Natl Acad Sci USA 86:3619, 1989
20. Hogg PJ, Jackson CM: Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex. J Biol Chem 265:241, 1990
21. Retzinger GS, Chandler LJ, Cook BC: Complexation with heparin prevents adhesion between fibrin-coated surfaces. J Biol Chem 267:24356, 1992
22. Hogg PJ, Jackson CM: Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates. J Biol Chem 265:248, 1990
23. Fears R: Kinetic studies on the effect of heparin and fibrin on plasminogen activators. Biochem J 249:77, 1988
24. Nenci GG, Parise P, Morini M, Rossini A, Agnelli G: Fibrin clots obtained from plasma containing heparin show a higher sensitivity to tissue plasminogen activator-induced lysis. Blood Coagul Fibrinolysis 3:279, 1992
25. Parise P, Morini M, Agnelli G, Ascani A, Nenci GG: Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to tissue plasminogen activator-induced lysis. Blood Coagul Fibrinolysis 4:721, 1993
26. Maciag T, Mehlman T, Friesel R, Schreiber AB: Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 225:932, 1984
27. Tannenbaum SH, Chao ES, Gralnick HR: Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms. Thromb Haemost 72:770, 1994
28. David G: Integral membrane heparan sulfate proteoglycans. FASEB J 7:1023, 1993
29. Hantgan RR, Francis CW, Marder VJ: Fibrinogen structure and physiology, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Haemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, p 277
30. Shainoff JR, Stearns DJ, DiBello PM, Hishikawa-Itoh Y: Characterization of a mode of specific binding of fibrin monomer through its amino-terminal domain by macrophages and macrophage cell-lines. Thromb Haemost 63:193, 1990
31. Lawrence SO, Wright TW, Francis CW, Fay PJ, Haidaris PJ: Purification and functional characterization of homodimeric γB-γB fibrinogen from rat plasma. Blood 82:2406, 1993
32. Zimmerman TS, Roberts J, Edgington TS: Factor VII-related antigen: Multiple molecular forms in human plasma. Proc Natl Acad Sci USA 72:5121, 1975
33. Fraker PJ, Speck JC Jr: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 80:849, 1978
34. Fujimura Y, Titani K, Holland LZ, Roberts JR, Kostel P, Ruggeri ZM: A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem 262:1734, 1987
35. Ugarova TP, Budzynski AZ: Interaction between complementary polymerization sites in the structural D and E domains of human fibrin. J Biol Chem 267:13687, 1992
36. Mohri H, Ohkubo T: Fibrinogen binds to heparin: The relationship of the binding of other adhesive proteins to heparin. Arch Biochem Biophys 303:27, 1993
37. Pandya BV, Gabriel JL, O'Brien J, Budzynski AZ: Polymerization site in the β chain of fibrin: Mapping of the Bβ 1-55 sequence. Biochemistry 30:162, 1991
38. 2-terminal region of fibrin. Mol Immunol 21:89, 1984
39. Hui KY, Haber E, Matsueda GR: Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222:1129, 1983
40. Acuna AU, Gonzalez-Rodriguez J, Lillo MP, Naqvi KR: Protein structure probed by polarization spectroscopy. II. A time-resolved fluorescence study of human fibrinogen. Biophys Chem 26:63, 1987
41. Hayashi M, Akama T, Kono I, Kishiwagi H: Activation of vitronectin (serum spreading factor) binding of heparin by denaturing agents. J Biochem 98:1135, 1985
42. Zammaron C, Ginsberg MH, Plow EF: Monoclonal antibodies specific for a conformationally altered state of fibrinogen. Thromb Haemost 64:41, 1990
43. Martinelli RA, Scheraga HA: Steady state kinetic study of the bovine thrombin-fibrinogen interaction. Biochemistry 19:2343, 1980
44. Hanna LS, Scheraga HA, Francis CW, Marder VJ: Comparison of structures of various fibrinogens and a derivative thereof by a study of kinetics of release of fibrinopeptides. Biochemistry 23:4681, 1984
45. Rosenberg RD, Bauer KA: The heparin-antithrombin III system: A natural anticoagulant mechanism, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Haemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lippincott, 1994, p 837
46. de Boer HC, Preissner KT, Bouma BN, de Groot PG: Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem 267:2264, 1992
47. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J: Fibrin II induces endothelial cell capillary tube formation. J Cell Biol 130:207, 1995